According to Biocon's latest financial reports and stock price the company's current Operating Margin is 12.16%. At the end of 2023 the company had an Operating Margin of 8.03%.
Year | Operating Margin | Change |
---|---|---|
2023 | 8.03% | -34.47% |
2022 | 12.25% | -20.75% |
2021 | 15.46% | -19.04% |
2020 | 19.09% | -15.43% |
2019 | 22.58% | 47.24% |
2018 | 15.33% | -30.6% |
2017 | 22.09% | -38.71% |
2016 | 36.05% | 76.69% |
2015 | 20.40% | 8.18% |
2014 | 18.86% | -25.02% |
2013 | 25.15% | 31.29% |
2012 | 19.16% | -1.45% |
2011 | 19.44% | 12.62% |
2010 | 17.26% | -8.93% |
2009 | 18.95% | -31.6% |
2008 | 27.71% | 8.04% |
2007 | 25.65% | -12.95% |
2006 | 29.46% | -11.47% |
2005 | 33.28% | 3.31% |
2004 | 32.21% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.